Press releases 2023
XNK Therapeutics one of three winners of Business Sweden’s Catalyst program 2023
XNK Therapeutics AB announced July 12, 2023 that it has been selected as one of three winners of Business Sweden’s Catalyst program 2023. The program identifies Swedish companies having the strongest prerequisites to scale up globally.
XNK receives certificate of GMP compliance of a manufacturer from the Medical Products Agency
XNK Therapeutics announced March 20, 2023 that XNK has received a GMP manufacturing license and a certificate of GMP compliance from the Swedish Medical Products Agency, which means that the company can produce at scale for its planned clinical studies.